av亚洲男人天堂,阿娇张开双腿实干十三分钟,亚洲AV成人午夜亚洲美女

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
20 mg	In-stock	￥408.00	登錄后可見	- +
50 mg	In-stock	￥472.00	登錄后可見	- +
100 mg	In-stock	￥678.00	登錄后可見	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

20 mg

In-stock

￥408.00

登錄后可見

- +

50 mg

In-stock

￥472.00

登錄后可見

- +

100 mg

In-stock

￥678.00

登錄后可見

- +

基本信息

英文名稱	Vatalanib Dihydrochloride \| Vatalanib 2HCl
中文名稱	瓦他拉尼二鹽酸鹽
CAS號(hào)	212141-51-0
分子式	C20H17Cl3N4
分子量	419.73
外觀	Off-white to pink powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Vatalanib (PTK787 or ZK-222584, cpg-79787 2HCl) 2HCl is a novel, potent and orally bioavailable inhibitor of VEGFR2/KDR with potential anticancer activity. In a cell-free experiment, it inhibits VEGFR2/KDR with an IC50 of 37 nM, is less effective against VEGFR1/Flt-1, and is 18-fold more potent against VEGFR3/Flt-4. With strong anti-proliferative activity in vitro and strong antitumor efficaciousness in vivo, it is an anilinophthalazine analog. The protein kinase domains of VEGFR 1 and 2 are bound by vatalanib, which then inhibits them. The PDGF receptor, c-Kit, and c-Fms are among the related receptor tyrosine kinases that this agent binds to and inhibits.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒有相關(guān)產(chǎn)品

瀏覽記錄

CL1906

瓦他拉尼二鹽酸鹽

212141-51-0 98+% In-stock

￥408.00 20 mg

欧美日韩成人一区二区三区,成人污污污WWW网站免费直播,久久综久久美利坚合众国,国产精品人妻一区二区三区四区

瓦他拉尼二鹽酸鹽

Vatalanib Dihydrochloride | Vatalanib 2HCl

化學(xué)品安全說明書(MSDS)

質(zhì)檢證書(COA)